Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RRM1 | P23921 | 1/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.44 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.42 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 6/20 | 0.41 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 4/20 | 0.41 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1374079 | 0.93 | DPP7 (0.44) | RRM1DPP7GNAI3GNAO1GNAI1 | |
| SCHEMBL16450582 | 0.86 | GNAI3 (0.59) | RRM1DPP7GNAI3GNAO1GNAI1 | |
| SCHEMBL15195578 | 0.86 | PRMT1 (0.55) | RRM1DPP7GNAI3GNAO1GNAI1 | |
| SCHEMBL3441238 | 0.85 | MEN1 (0.50) | RRM1DPP7GNAI3GNAO1GNAI1 | |
| SCHEMBL453916 | 0.85 | MEN1 (0.50) | RRM1DPP7GNAI3GNAO1GNAI1 | |
| SCHEMBL16124665 | 0.84 | DPP7 (0.67) | RRM1DPP7GNAI3GNAO1GNAI1 | |
| SCHEMBL1976979 | 0.84 | DPP7 (0.67) | RRM1DPP7GNAI3GNAO1GNAI1 | |
| SCHEMBL7770773 | 0.84 | DPP7 (0.67) | RRM1DPP7GNAI3GNAO1GNAI1 | |
| SCHEMBL3876752 | 0.84 | DPP7 (0.67) | RRM1DPP7GNAI3GNAO1GNAI1 | |
| SCHEMBL7769954 | 0.84 | DPP7 (0.67) | RRM1DPP7GNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240366519-A1 | NANOPARTICLE DELIVERY SYSTEMS | CELATOR PHARMACEUTICALS, INC. (US) | 2024-11-07 | — | — | US | disclosed |
| US-11413253-B2 | Nanoparticle delivery systems | CELATOR PHARMACEUTICALS, INC. (US) | 2022-08-16 | — | — | US | disclosed |
| WO-2010008876-A2 | METHOD FOR PREPARATION OF MICELLAR HYBRID NANOPARTICLES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS AND COMPOSITIONS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11413253-B2 | Nanoparticle delivery systems | PAICS, ABCB1, TSG101 | RRM1 1334/4885DPP7 339/4885GNAI3 1594/4885 |
| US-20240366519-A1 | NANOPARTICLE DELIVERY SYSTEMS | PAICS, ABCB1, TSG101 | RRM1 1334/4885DPP7 339/4885GNAI3 1594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.